Skip to main content
Clinical Trials/CTRI/2022/11/047678
CTRI/2022/11/047678Not yet recruitingPhase 4

A clinical study on effect of Rumavin capsule in the patients of joint related pain

The Punarvasu (Petlad Mahal Arogya Mandal Pharmacy)0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 4
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • 1. Individuals between the age group of 18 to 80 years of both genders having clinical features of joint pain.
  • 2. Patient with affection of joint pain, presenting with Sandhishotha (swelling over joints), Sandhishula (pain in joints), Sandhigraha (stiffness in joints), Sprarshasahatva (tenderness) and Sandhisphutna (crepitus).
  • 3. VAS more then 4.
  • 4. Radiology of the affected joints was not carried out because those patients who were included in the study have already been diagnosed radiologically.

Exclusion Criteria

  • 1. Female patients having pregnancy, breast feeding or post-delivery period.
  • 2. Patients who have done any operation of joint.
  • 3. Patients who had an association with other diseases like diabetes mellitus.
  • 4. Patients below 18 years and above 80 years of age
  • ï?­Patients with some serious illness like cardio-vascular diseases,acute mental disorders, serious acute organic diseases, serious chronic co-morbidity, hypo or hyper thyroidism, other kidney, liver or metabolic disorders etc.

Investigators

Sponsor
The Punarvasu (Petlad Mahal Arogya Mandal Pharmacy)

Similar Trials